Public-Private Japan Fund To Buy 20% Stake In Prism Pharma
This article was originally published in PharmAsia News
Executive Summary
Prism Pharma, which is working on drugs with Eisai, is about to sell a 20% stake to Innovation Network Corp. of Japan, a public-private venture fund that expects the deal to be completed yet this month.